mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |